UNITED STATES ANTI-DOPING AGENCY REAUTHORIZATION ACT; Congressional Record Vol. 160, No. 152
(House of Representatives - December 12, 2014)

Text available as:

Formatting necessary for an accurate reading of this text may be shown by tags (e.g., <DELETED> or <BOLD>) or may be missing from this TXT display. For complete and accurate display of this text, see the PDF.


[Page H10314]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]




          UNITED STATES ANTI-DOPING AGENCY REAUTHORIZATION ACT

  Mr. FLORES. Mr. Speaker, I ask unanimous consent to take from the 
Speaker's table the bill (S. 2338) to reauthorize the United States 
Anti-Doping Agency, and for other purposes, and ask for its immediate 
consideration in the House.
  The Clerk read the title of the bill.
  The SPEAKER pro tempore. Is there objection to the request of the 
gentleman from Texas?
  There was no objection.
  The text of the bill is as follows:

                                S. 2338

       Be it enacted by the Senate and House of Representatives of 
     the United States of America in Congress assembled,

     SECTION 1. SHORT TITLE.

       This Act may be cited as the ``United States Anti-Doping 
     Agency Reauthorization Act''.

     SEC. 2. PROHIBIT PERFORMANCE-ENHANCING METHODS.

       Section 701 of title VII of the Office of National Drug 
     Control Policy Reauthorization Act of 2006 (21 U.S.C. 2001) 
     is amended--
       (1) in subsection (a), by striking paragraph (4); and
       (2) in subsection (b)--
       (A) in paragraph (1), by inserting ``and be recognized 
     worldwide as the independent national anti-doping 
     organization for the United States'' after ``Committee'';
       (B) in paragraph (2), by striking ``, or performance-
     enhancing genetic modifications accomplished through gene-
     doping'' and inserting ``or prohibited performance-enhancing 
     methods adopted by the Agency'';
       (C) in paragraph (3), by striking ``, or performance-
     enhancing genetic modifications accomplished through gene-
     doping'' and inserting ``or prohibited performance-enhancing 
     methods adopted by the Agency'';
       (D) in paragraph (4), by striking ``and the prevention of 
     use of performance-enhancing drugs, or performance-enhancing 
     genetic modifications accomplished through gene-doping by 
     United States amateur athletes; and'' and inserting ``, and 
     the prevention of use by United States amateur athletes of 
     performance-enhancing drugs or prohibited performance-
     enhancing methods adopted by the Agency.''; and
       (E) by striking paragraph (5).

     SEC. 3. AUTHORIZATION OF APPROPRIATIONS.

       Section 703 of title VII of the Office of National Drug 
     Control Policy Reauthorization Act of 2006 (21 U.S.C. 2003) 
     is amended to read as follows:

     ``SEC. 703. AUTHORIZATION OF APPROPRIATIONS.

       ``There are authorized to be appropriated to the United 
     States Anti-Doping Agency--
       ``(1) for fiscal year 2014, $11,300,000;
       ``(2) for fiscal year 2015, $11,700,000;
       ``(3) for fiscal year 2016, $12,300,000;
       ``(4) for fiscal year 2017, $12,900,000;
       ``(5) for fiscal year 2018, $13,500,000;
       ``(6) for fiscal year 2019, $14,100,000; and
       ``(7) for fiscal year 2020, $14,800,000.''.

  The bill was ordered to be read a third time, was read the third 
time, and passed, and a motion to reconsider was laid on the table.

                          ____________________